Cat. No.: X23-10-ZQ604
PGE synthase inhibitor SAR191801, Purity ≥98%
Synonym: 1234708-04-3; hPGDS-IN-1; SAR191801; N-(3-(5-(2-Hydroxypropan-2-yl)-1,2,4-oxadiazol-3-yl)benzyl)-2-(pyridin-2-yl)pyrimidine-5-carboxamide; N-({3-[5-(2-Hydroxypropan-2-yl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)-2-(pyridin-2-yl)pyrimidine-5-carboxamide; 2-Pyridin-2-yl-pyrimidine-5-carboxylic acid 3-[5-(1-hydroxy-1-methyl-ethyl)-1,2,4-oxadiazol-3-yl]-benzylamide; N-[[3-[5-(1-Hydroxy-1-methylethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-2-(2-pyridinyl)-5-pyrimidinecarboxamide; PGE synthase inhibitor
- MDL: MFCD28963902
- CAS Number: 1234708-04-3
- Compound CID: 46700750
Product Size
2 mg; 5 mg; 10 mg; 25 mg
Properties
Description
SAR191801 is a PGE synthase inhibitor.
Molecular Formula
C22H20N6O3
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
SAR191801 can be utilized in research focusing on its role as a GPR120 agonist in metabolic and inflammatory conditions.
Related Products
